Société Day One Biopharmaceuticals, Inc.
Actions
DAWN
US23954D1090
Recherche biotechnologique et médicale
Marché Fermé -
Autres places de cotation
|
Varia. 5j. | Varia. 1 janv. | ||
12,75 USD | -3,26 % | -6,32 % | -12,67 % |
Métier
Nombre d'employés: 174
Dirigeants
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Samuel Blackman
FOU | Founder | 55 | 01/11/18 |
Jeremy Bender
CEO | Chief Executive Officer | 52 | 01/09/20 |
Charles York
DFI | Director of Finance/CFO | 47 | 01/02/21 |
Mike Pregih
CTO | Chief Tech/Sci/R&D Officer | - | - |
Adam Dubow
CMP | Compliance Officer | 57 | 01/10/22 |
Davy Chiodin
PRN | Corporate Officer/Principal | - | - |
Lauren Merendino
PRN | Corporate Officer/Principal | 49 | 01/05/23 |
Jaa Roberson
HRO | Human Resources Officer | - | 13/09/21 |
Raphaël Rousseau
PRN | Corporate Officer/Principal | 55 | 01/05/23 |
Administrateurs
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
J. Garland
BRD | Director/Board Member | 55 | 17/08/21 |
Natalie Holles
BRD | Director/Board Member | 51 | 01/02/21 |
John Josey
BRD | Director/Board Member | 63 | 01/09/20 |
Jeremy Bender
CEO | Chief Executive Officer | 52 | 01/09/20 |
Director/Board Member | 37 | 01/12/19 | |
Director/Board Member | 48 | 01/03/21 | |
William Grossman
BRD | Director/Board Member | 54 | 17/01 |
Garry Nicholson
CHM | Chairman | 69 | 12/09/22 |
Habib Dable
BRD | Director/Board Member | 54 | 17/01 |
Classe d'actions
Vote | Nombre | Flottant | Autocontrôle | Flottant Total | |
---|---|---|---|---|---|
Action A | 1 | 87 389 859 | 70 160 882 ( 80,28 %) | 0 | 80,28 % |
Coordonnées société
Day One Biopharmaceuticals, Inc.
2000 Sierra Point Parkway Suite 501
94005, Brisbane
+
http://www.dayonebio.comSecteur
Révisions de BNA
Varia. 1 janv. | Capi. | |
---|---|---|
-12,67 % | 1,15 Md | |
+46,19 % | 56,65 Md | |
-6,14 % | 39,44 Md | |
+39,19 % | 39,03 Md | |
-6,65 % | 26,86 Md | |
+12,33 % | 26,75 Md | |
-21,78 % | 19,03 Md | |
-0,35 % | 12,28 Md | |
+24,18 % | 12,26 Md | |
+28,38 % | 12,04 Md |
- Bourse
- Actions
- Action DAWN
- Société Day One Biopharmaceuticals, Inc.